The respiratory devices and equipment (diagnostic) market size has grown strongly in recent years. It will grow from $8.36 billion in 2025 to $9.18 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to increasing prevalence of respiratory disorders, expansion of pulmonary diagnostic laboratories, rising demand for early disease diagnosis, availability of advanced spirometry devices, growing use of oxygen monitoring tools.
The respiratory devices and equipment (diagnostic) market size is expected to see strong growth in the next few years. It will grow to $13.29 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to growing investments in respiratory disease diagnostics, increasing adoption of molecular and imaging-based tests, expansion of home-based diagnostic monitoring, rising focus on personalized respiratory care, continued innovation in diagnostic assay development. Major trends in the forecast period include increasing adoption of portable diagnostic respiratory devices, rising use of molecular diagnostic tests for respiratory diseases, growing integration of ai-based lung function analysis, expansion of point-of-care respiratory testing, enhanced focus on early disease detection.
The rising prevalence of various respiratory diseases is anticipated to drive the growth of the respiratory devices and equipment (diagnostic) market in the coming years. Respiratory diseases are medical conditions that affect the lungs and airways, disrupting normal breathing and oxygen exchange due to factors such as inflammation, infection, obstruction, or chronic structural damage. The increasing prevalence of respiratory diseases is attributed to the growing global burden of conditions that progressively reduce lung function and heighten susceptibility to long-term respiratory complications. Respiratory devices and equipment support the management of these diseases by improving airflow, enhancing oxygen delivery, and enabling more effective monitoring of lung function to help stabilize patient health. For example, in June 2025, according to the World Health Organization, a Switzerland-based organization, 81.7 million people are living with chronic respiratory diseases, and 6.8 million new cases are diagnosed each year. Therefore, the growing prevalence of respiratory diseases is contributing to the expansion of the respiratory devices and equipment (diagnostic) market.
Leading companies in the respiratory devices and equipment (diagnostic) market are focusing on developing advanced diagnostic technologies, such as automated nucleic acid purification instruments and the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit, to improve the accuracy and speed of viral detection. These instruments and kits enable the quick and reliable extraction of viral genetic material for precise diagnostic testing. For instance, in December 2023, Thermo Fisher Scientific Inc., a U.S.-based biotechnology company, introduced Sample Preparation Solutions for Respiratory Diagnostic Testing. The Thermo Scientific KingFisher Apex Dx automates the purification of up to 24 or 96 samples of DNA, RNA, proteins, or cells, ensuring high-quality results for respiratory tests. It integrates with the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit, providing a comprehensive solution for in vitro diagnostics. With advanced data management and cybersecurity features, this system supports smooth workflows from sample preparation to real-time PCR analysis, making it suitable for both research and diagnostic purposes.
In May 2025, ResMed Inc., a US-based leader in sleep, breathing, and home healthcare devices, acquired VirtuOx for an undisclosed amount. Through this acquisition, ResMed seeks to enhance its virtual care and in-home diagnostic capabilities by integrating VirtuOx’s at-home testing services into its ecosystem, enabling earlier diagnosis and a more connected care pathway. VirtuOx is a US-based company that provides a virtual testing platform for sleep-disordered breathing and other respiratory conditions.
Major companies operating in the respiratory devices and equipment (diagnostic) market are ResMed Inc., Medtronic plc, Masimo Corporation, Fisher & Paykel Healthcare Limited, Koninklijke Philips N.V., Smiths Medical, GE Healthcare, Chart Industries Inc., Philips Healthcare, Becton Dickinson and Company (BD), Abbott Laboratories, Thermo Fisher Scientific Inc., Teleflex Incorporated, Invacare Corporation, Vyaire Medical Inc., Drägerwerk AG & Co. KGaA, Getinge AB, Dräger Medical GmbH, bioMérieux, Bio-Rad Laboratories Inc - Bio-Rad Laboratories Inc., Cosmed S.r.l., Seegene Inc., SDI Diagnostics, GlaxoSmithKline plc, Hillrom, Hamilton Medical AG, Medline Industries Inc., 3M Company, Air Liquide, Allied Healthcare Products Inc., Armstrong Medical, Bio-Med Devices Inc., Breas Medical AB, CAIRE Inc., DeVilbiss Healthcare, Nihon Kohden Corporation, O2 Concepts LLC.
Asia-Pacific was the largest region in the respiratory devices and equipment (diagnostic) market in 2025. North America was the second largest region in the respiratory devices and equipment (diagnostic) market. The regions covered in the respiratory devices and equipment (diagnostic) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the respiratory devices and equipment (diagnostic) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the respiratory devices and equipment (diagnostic) market by increasing costs of imported diagnostic instruments, reagents, imaging components, sensors, and electronic control units. Hospital laboratories and diagnostic centers in North America and Europe are most affected due to reliance on imported testing equipment, while Asia-Pacific faces increased production costs for diagnostic consumables. These tariffs are increasing test costs and slowing laboratory upgrades. However, they are also supporting domestic reagent manufacturing, regional device production, and localized development of respiratory diagnostic technologies.
The respiratory devices and equipment (diagnostic) market research report is one of a series of new reports that provides respiratory devices and equipment (diagnostic) market statistics, including respiratory devices and equipment (diagnostic) industry global market size, regional shares, competitors with a respiratory devices and equipment (diagnostic) market share, detailed respiratory devices and equipment (diagnostic) market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory devices and equipment (diagnostic) industry. This respiratory devices and equipment (diagnostic) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Respiratory diagnostic devices and equipment are used to diagnose respiratory conditions like asthma, cystic fibrosis, and chronic obstructive pulmonary disease. These devices help measure lung function and oxygen levels, assisting healthcare providers in assessing and managing respiratory health.
The primary products within the respiratory devices and equipment (diagnostic) market encompass instruments and devices, as well as assays and reagents. These respiratory instruments and devices are critical for the diagnosis of various respiratory disorders. Diagnostic tests are available in various types, including traditional diagnostic tests, mechanical tests, imaging tests, and molecular diagnostic tests, all of which are employed in diagnosing conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, asthma, tuberculosis, and other respiratory diseases. These diagnostic tools are used in a variety of healthcare settings, including hospital and clinical laboratories, physician offices, reference laboratories, and other end-user facilities.
The respiratory devices and equipment (diagnostic) market consist of sales of spirometer, polysomnographs, and peak flow meters and monitoring devices are pulse oximeters, capnography, and gas analyzers that are used for diagnosis of respiratory diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The respiratory devices and equipment (diagnostic) market size is expected to see strong growth in the next few years. It will grow to $13.29 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to growing investments in respiratory disease diagnostics, increasing adoption of molecular and imaging-based tests, expansion of home-based diagnostic monitoring, rising focus on personalized respiratory care, continued innovation in diagnostic assay development. Major trends in the forecast period include increasing adoption of portable diagnostic respiratory devices, rising use of molecular diagnostic tests for respiratory diseases, growing integration of ai-based lung function analysis, expansion of point-of-care respiratory testing, enhanced focus on early disease detection.
The rising prevalence of various respiratory diseases is anticipated to drive the growth of the respiratory devices and equipment (diagnostic) market in the coming years. Respiratory diseases are medical conditions that affect the lungs and airways, disrupting normal breathing and oxygen exchange due to factors such as inflammation, infection, obstruction, or chronic structural damage. The increasing prevalence of respiratory diseases is attributed to the growing global burden of conditions that progressively reduce lung function and heighten susceptibility to long-term respiratory complications. Respiratory devices and equipment support the management of these diseases by improving airflow, enhancing oxygen delivery, and enabling more effective monitoring of lung function to help stabilize patient health. For example, in June 2025, according to the World Health Organization, a Switzerland-based organization, 81.7 million people are living with chronic respiratory diseases, and 6.8 million new cases are diagnosed each year. Therefore, the growing prevalence of respiratory diseases is contributing to the expansion of the respiratory devices and equipment (diagnostic) market.
Leading companies in the respiratory devices and equipment (diagnostic) market are focusing on developing advanced diagnostic technologies, such as automated nucleic acid purification instruments and the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit, to improve the accuracy and speed of viral detection. These instruments and kits enable the quick and reliable extraction of viral genetic material for precise diagnostic testing. For instance, in December 2023, Thermo Fisher Scientific Inc., a U.S.-based biotechnology company, introduced Sample Preparation Solutions for Respiratory Diagnostic Testing. The Thermo Scientific KingFisher Apex Dx automates the purification of up to 24 or 96 samples of DNA, RNA, proteins, or cells, ensuring high-quality results for respiratory tests. It integrates with the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit, providing a comprehensive solution for in vitro diagnostics. With advanced data management and cybersecurity features, this system supports smooth workflows from sample preparation to real-time PCR analysis, making it suitable for both research and diagnostic purposes.
In May 2025, ResMed Inc., a US-based leader in sleep, breathing, and home healthcare devices, acquired VirtuOx for an undisclosed amount. Through this acquisition, ResMed seeks to enhance its virtual care and in-home diagnostic capabilities by integrating VirtuOx’s at-home testing services into its ecosystem, enabling earlier diagnosis and a more connected care pathway. VirtuOx is a US-based company that provides a virtual testing platform for sleep-disordered breathing and other respiratory conditions.
Major companies operating in the respiratory devices and equipment (diagnostic) market are ResMed Inc., Medtronic plc, Masimo Corporation, Fisher & Paykel Healthcare Limited, Koninklijke Philips N.V., Smiths Medical, GE Healthcare, Chart Industries Inc., Philips Healthcare, Becton Dickinson and Company (BD), Abbott Laboratories, Thermo Fisher Scientific Inc., Teleflex Incorporated, Invacare Corporation, Vyaire Medical Inc., Drägerwerk AG & Co. KGaA, Getinge AB, Dräger Medical GmbH, bioMérieux, Bio-Rad Laboratories Inc - Bio-Rad Laboratories Inc., Cosmed S.r.l., Seegene Inc., SDI Diagnostics, GlaxoSmithKline plc, Hillrom, Hamilton Medical AG, Medline Industries Inc., 3M Company, Air Liquide, Allied Healthcare Products Inc., Armstrong Medical, Bio-Med Devices Inc., Breas Medical AB, CAIRE Inc., DeVilbiss Healthcare, Nihon Kohden Corporation, O2 Concepts LLC.
Asia-Pacific was the largest region in the respiratory devices and equipment (diagnostic) market in 2025. North America was the second largest region in the respiratory devices and equipment (diagnostic) market. The regions covered in the respiratory devices and equipment (diagnostic) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the respiratory devices and equipment (diagnostic) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the respiratory devices and equipment (diagnostic) market by increasing costs of imported diagnostic instruments, reagents, imaging components, sensors, and electronic control units. Hospital laboratories and diagnostic centers in North America and Europe are most affected due to reliance on imported testing equipment, while Asia-Pacific faces increased production costs for diagnostic consumables. These tariffs are increasing test costs and slowing laboratory upgrades. However, they are also supporting domestic reagent manufacturing, regional device production, and localized development of respiratory diagnostic technologies.
The respiratory devices and equipment (diagnostic) market research report is one of a series of new reports that provides respiratory devices and equipment (diagnostic) market statistics, including respiratory devices and equipment (diagnostic) industry global market size, regional shares, competitors with a respiratory devices and equipment (diagnostic) market share, detailed respiratory devices and equipment (diagnostic) market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory devices and equipment (diagnostic) industry. This respiratory devices and equipment (diagnostic) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Respiratory diagnostic devices and equipment are used to diagnose respiratory conditions like asthma, cystic fibrosis, and chronic obstructive pulmonary disease. These devices help measure lung function and oxygen levels, assisting healthcare providers in assessing and managing respiratory health.
The primary products within the respiratory devices and equipment (diagnostic) market encompass instruments and devices, as well as assays and reagents. These respiratory instruments and devices are critical for the diagnosis of various respiratory disorders. Diagnostic tests are available in various types, including traditional diagnostic tests, mechanical tests, imaging tests, and molecular diagnostic tests, all of which are employed in diagnosing conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, asthma, tuberculosis, and other respiratory diseases. These diagnostic tools are used in a variety of healthcare settings, including hospital and clinical laboratories, physician offices, reference laboratories, and other end-user facilities.
The respiratory devices and equipment (diagnostic) market consist of sales of spirometer, polysomnographs, and peak flow meters and monitoring devices are pulse oximeters, capnography, and gas analyzers that are used for diagnosis of respiratory diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Respiratory Devices and Equipment (Diagnostic) Market Characteristics
3. Respiratory Devices and Equipment (Diagnostic) Market Supply Chain Analysis
4. Global Respiratory Devices and Equipment (Diagnostic) Market Trends and Strategies
5. Respiratory Devices and Equipment (Diagnostic) Market Analysis of End Use Industries
7. Global Respiratory Devices and Equipment (Diagnostic) Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Respiratory Devices and Equipment (Diagnostic) Total Addressable Market (TAM) Analysis for the Market
9. Respiratory Devices and Equipment (Diagnostic) Market Segmentation
10. Respiratory Devices and Equipment (Diagnostic) Market Regional and Country Analysis
11. Asia-Pacific Respiratory Devices and Equipment (Diagnostic) Market
12. China Respiratory Devices and Equipment (Diagnostic) Market
13. India Respiratory Devices and Equipment (Diagnostic) Market
14. Japan Respiratory Devices and Equipment (Diagnostic) Market
15. Australia Respiratory Devices and Equipment (Diagnostic) Market
16. Indonesia Respiratory Devices and Equipment (Diagnostic) Market
17. South Korea Respiratory Devices and Equipment (Diagnostic) Market
18. Taiwan Respiratory Devices and Equipment (Diagnostic) Market
19. South East Asia Respiratory Devices and Equipment (Diagnostic) Market
20. Western Europe Respiratory Devices and Equipment (Diagnostic) Market
21. UK Respiratory Devices and Equipment (Diagnostic) Market
22. Germany Respiratory Devices and Equipment (Diagnostic) Market
23. France Respiratory Devices and Equipment (Diagnostic) Market
24. Italy Respiratory Devices and Equipment (Diagnostic) Market
25. Spain Respiratory Devices and Equipment (Diagnostic) Market
26. Eastern Europe Respiratory Devices and Equipment (Diagnostic) Market
27. Russia Respiratory Devices and Equipment (Diagnostic) Market
28. North America Respiratory Devices and Equipment (Diagnostic) Market
29. USA Respiratory Devices and Equipment (Diagnostic) Market
30. Canada Respiratory Devices and Equipment (Diagnostic) Market
31. South America Respiratory Devices and Equipment (Diagnostic) Market
32. Brazil Respiratory Devices and Equipment (Diagnostic) Market
33. Middle East Respiratory Devices and Equipment (Diagnostic) Market
34. Africa Respiratory Devices and Equipment (Diagnostic) Market
36. Respiratory Devices and Equipment (Diagnostic) Market Competitive Landscape and Company Profiles
37. Respiratory Devices and Equipment (Diagnostic) Market Other Major and Innovative Companies
40. Respiratory Devices and Equipment (Diagnostic) Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Respiratory Devices And Equipment (Diagnostic) Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses respiratory devices and equipment (diagnostic) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for respiratory devices and equipment (diagnostic)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The respiratory devices and equipment (diagnostic) market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Instruments And Devices; Assays And Reagents2) By Test Type: Traditional Diagnostic Tests; Mechanical Tests; Imaging Tests; Molecular Diagnostic Tests
3) By Disease Type: Chronic Obstructive Pulmonary Disease; Lung Cancer; Asthma; Tuberculosis; Other Diseases
4) By End User: Hospital/Clinical Laboratories; Physician Offices; Reference Laboratories; Other End Users
Subsegments:
1) By Instruments And Devices: Spirometers; Pulse Oximeters; Peak Flow Meters; Capnographs; Respiratory Pressure Monitors; Portable Ventilators2) By Assays And Reagents: Diagnostic Kits; Reagents For Respiratory Infections; Blood Gas Analysis Reagents; PCR Assays For Respiratory Pathogens
Companies Mentioned: ResMed Inc.; Medtronic plc; Masimo Corporation; Fisher & Paykel Healthcare Limited; Koninklijke Philips N.V.; Smiths Medical; GE Healthcare; Chart Industries Inc.; Philips Healthcare; Becton Dickinson and Company (BD); Abbott Laboratories; Thermo Fisher Scientific Inc.; Teleflex Incorporated; Invacare Corporation; Vyaire Medical Inc.; Drägerwerk AG & Co. KGaA; Getinge AB; Dräger Medical GmbH; bioMérieux; Bio-Rad Laboratories Inc - Bio-Rad Laboratories Inc.; Cosmed S.r.l.; Seegene Inc.; SDI Diagnostics; GlaxoSmithKline plc; Hillrom; Hamilton Medical AG; Medline Industries Inc.; 3M Company; Air Liquide; Allied Healthcare Products Inc.; Armstrong Medical; Bio-Med Devices Inc.; Breas Medical AB; CAIRE Inc.; DeVilbiss Healthcare; Nihon Kohden Corporation; O2 Concepts LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Respiratory Devices and Equipment (Diagnostic) market report include:- ResMed Inc.
- Medtronic plc
- Masimo Corporation
- Fisher & Paykel Healthcare Limited
- Koninklijke Philips N.V.
- Smiths Medical
- GE Healthcare
- Chart Industries Inc.
- Philips Healthcare
- Becton Dickinson and Company (BD)
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- Teleflex Incorporated
- Invacare Corporation
- Vyaire Medical Inc.
- Drägerwerk AG & Co. KGaA
- Getinge AB
- Dräger Medical GmbH
- bioMérieux
- Bio-Rad Laboratories Inc - Bio-Rad Laboratories Inc.
- Cosmed S.r.l.
- Seegene Inc.
- SDI Diagnostics
- GlaxoSmithKline plc
- Hillrom
- Hamilton Medical AG
- Medline Industries Inc.
- 3M Company
- Air Liquide
- Allied Healthcare Products Inc.
- Armstrong Medical
- Bio-Med Devices Inc.
- Breas Medical AB
- CAIRE Inc.
- DeVilbiss Healthcare
- Nihon Kohden Corporation
- O2 Concepts LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 9.18 Billion |
| Forecasted Market Value ( USD | $ 13.29 Billion |
| Compound Annual Growth Rate | 9.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 38 |
